18 employees
ZTI Biosciences develops therapeutic radiopharmaceuticals for intractable and recurring solid cancers.
2020
$1.2M
from 1 investors over 1 rounds
ZTI BIOSCIENCES raised $1.2M on September 30, 2021
Investors: Kiwoom Investment